Showing results (331-340 of 359) with videos related to
Sort By:
Pageof 36
Clinical Transplantation|July 17, 2019
Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer GroupJames Paul O'Neill, Donal J Sexton, Eamonn O'Leary, et al.Human Gene Therapy|September 1, 2006
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosisSamuel G Jacobson, Sanford L Boye, Tomas S Aleman, et al.Journal of Nephrology|January 29, 2025
Phenotypic outcomes of PKD1 compared with non-PKD1 genetically confirmed autosomal dominant polycystic kidney diseaseElhussein A E Elhassan, Darragh O'Donoghue, Sophia Heneghan, et al.Human Molecular Genetics|April 27, 2011
Pompe disease gene therapyBarry J Byrne, Darin J Falk, Christina A Pacak, et al.Journal of Nephrology|January 31, 2022
The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene ProjectElhussein A E Elhassan, Susan L Murray, Dervla M Connaughton, et al.Journal of the American Society of Nephrology : JASN|April 17, 2021
A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 (<i>RCAN1</i>) Gene Confers Enhanced Calcineurin Activity and May Cause FSGSBrandon M Lane, Susan Murray, Katherine Benson, et al.Kidney International|September 18, 2014
Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosisAndrew F Malone, Paul J Phelan, Gentzon Hall, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2022
An intermediate-effect size variant in <i>UMOD</i> confers risk for chronic kidney diseaseEric Olinger, Céline Schaeffer, Kendrah Kidd, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2006
Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injectionSamuel G Jacobson, Gregory M Acland, Gustavo D Aguirre, et al.BMC Nephrology|December 19, 2024
Eight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational studyKendrah O Kidd, Adrienne H Williams, Abbigail Taylor, et al.Pageof 36